Discover the Best Stocks and Maximize Your Portfolio:
- See what stocks are receiving strong buy ratings from top-rated analysts.
- Filter, analyze, and streamline your search for investment opportunities with TipRanks’ Stock Screener.
An announcement from NewGenIvf Group ( (NIVF) ) is now available.
NewGenIvf Group Limited received approval from the Nasdaq Hearings Panel to continue its listing on the Nasdaq Stock Market, contingent upon meeting specific conditions. The company has already taken steps towards compliance, including a reverse stock split and meeting shareholder equity requirements. NewGen also appointed Thorain Ko as the Business Development Director to expand its lifetime egg-freezing business in China and other Asian markets, aiming to enhance its growth and stakeholder value.
More about NewGenIvf Group
NewGenIvf Group Limited is a comprehensive fertility services provider operating in Asia, focusing on helping couples and individuals access fertility treatments. The company offers a full suite of services including infertility and assisted reproductive technology treatments, egg and sperm donation, and surrogacy, with clinics located in Thailand, Cambodia, and Kyrgyzstan.
YTD Price Performance: -71.98%
Average Trading Volume: 737,586
Technical Sentiment Consensus Rating: Buy
Current Market Cap: $1.11M
For an in-depth examination of NIVF stock, go to TipRanks’ Stock Analysis page.
